Skip to main content

Parkinson's - TOPAZ

Status: Closed to Enrollment

Study Details

View study details on www.clinicaltrials.gov.

Locations

  • Berkeley
  • Sacramento

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's Disease

Please contact: Yomi Kapasi, CRC East Bay

Please contact: ClinicalResearch@sutterhealth.org for Sacramento/Valley Area

Matthew W. Arnold
Matthew W. Arnold
Principal investigator
View Profile
Nicklesh Thakur
Nicklesh Thakur
Principal investigator
View Profile

Co-investigator

Erica A. Byrd

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?